Viridian Therapeutics
VRDN
VRDN
33 hedge funds and large institutions have $7.95M invested in Viridian Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
76% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 17
80% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 15
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$49.3K | |
| 2 | +$35.7K | |
| 3 | +$25.3K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$11.4K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$5.84K |
Top Sellers
| 1 | -$399K | |
| 2 | -$363K | |
| 3 | -$316K | |
| 4 |
Millennium Management
New York
|
-$286K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$239K |